Join Chamber Hill Strategies’ Melissa Bartlett for a panel discussion on CURES 2.0 Legislation and Patient-Focused Drug Development Opportunities as part of the BIO CEO & Investor Conference next week.
Registration is now open: https://bit.ly/3k2bwZJ